Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes

Caroline Pinet, Vincent Algalarrondo, Sylvie Sablayrolles, Bruno Le Grand, Christophe Pignier, Didier Cussac, Michel Perez, Stephane N. Hatem and Alain Coulombe
Molecular Pharmacology June 2008, 73 (6) 1622-1631; DOI: https://doi.org/10.1124/mol.107.043182
Caroline Pinet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Algalarrondo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Sablayrolles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Le Grand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Pignier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Cussac
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Perez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephane N. Hatem
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Coulombe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

After the thrombus formation in cardiac cavities or coronaries, the serine protease thrombin is produced and can therefore reach the myocardial tissue by the active process of extravasation and binds to the G protein-coupled protease-activated receptor-1 (PAR1) expressed in human myocardium. The role of PAR1 was investigated in the thrombin effect on sodium current (INa). INa was recorded in freshly isolated human atrial myocytes by the whole-cell patch-clamp method. Action potentials (AP) were recorded in guinea pig ventricular tissue by the conventional glass microelectrode technique. Thrombin-activated PAR1 induced a tetrodotoxin-blocked persistent sodium current, INaP, in a concentration-dependent manner with an apparent EC50 of 28 U/ml. The PAR1 agonist peptide SFLLR-NH2 (50 μM) was able to mimic PAR1-thrombin action, whereas PAR1 antagonists N3-cyclopropyl-7-((4-(1-methylethyl)-phenyl)methyl)-7H-pyrrolo(3,2-f)quinazoline-1,3-diamine (SCH 203099; 10 μM) and 1-(3,5-di-tert-butyl-4-hydroxy-phenyl)-2-[3-(3-ethyl-3-hydroxy-pentyl)-2-imino-2,3-dihydro-imidazol-1-yl]-ethanone (ER 112787) (1 μM), completely inhibited it. The activated PAR1 involves the calcium-independent phospholipase-A2 signaling pathway because two inhibitors of this cascade, bromoenol lactone (50 μM) and haloenol lactone suicide substrate (50 μM), block PAR1-thrombin-induced INaP.Asa consequence of INaP activation, in guinea pig right ventricle papillary muscle, action potential duration (APD) were significantly increased by 20% and 15% under the respective action of 32 U/ml thrombin and 50 μM SFLLR-NH2, and these increases in APD were prevented by 1 μM tetrodotoxin or markedly reduced by application of 1 μM SCH 203099 or ER 112787. Thrombin, through PAR1 activation, increases persistent component of the Na+ current resulting in an uncontrolled sodium influx into the cardiomyocyte, which can contribute to cellular injuries observed during cardiac ischemia.

Footnotes

  • This work was partly supported by Agence Nationale de la Recherche ANR-05-PCOD-006-01. C.P. was a recipient of grants from the Fondation Lefoulon Delalande and Association Française contre les Myopathies.

  • C.Pinet and V.A. contributed equally to this study.

  • ABBREVIATIONS: PAR, protease-activated receptor; HELSS, haloenol lactone suicide substrate; SCH 203099, N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3,2-f)quinazoline-1,3-diamine; HP, holding potential; AP, action potential; APD, action potential duration; TTX, tetrodotoxin; PLA2, phospholipase A2; LPC, lysophosphatidyl choline; BEL, bromoenol lactone; ER 112787, 1-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-[3-(3-ethyl-3-hydroxy-pentyl)-2-imino-2,3-dihydro-imidazol-1-yl]-ethanone.

  • ↵1 Current affiliation: Centre National de la Recherche Scientifique UMR 6187, Institut de Physiologie et de Biologie Cellulaire, Université de Poitiers, Poitiers, France.

    • Received November 5, 2007.
    • Accepted March 6, 2008.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 73 (6)
Molecular Pharmacology
Vol. 73, Issue 6
1 Jun 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes

Caroline Pinet, Vincent Algalarrondo, Sylvie Sablayrolles, Bruno Le Grand, Christophe Pignier, Didier Cussac, Michel Perez, Stephane N. Hatem and Alain Coulombe
Molecular Pharmacology June 1, 2008, 73 (6) 1622-1631; DOI: https://doi.org/10.1124/mol.107.043182

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes

Caroline Pinet, Vincent Algalarrondo, Sylvie Sablayrolles, Bruno Le Grand, Christophe Pignier, Didier Cussac, Michel Perez, Stephane N. Hatem and Alain Coulombe
Molecular Pharmacology June 1, 2008, 73 (6) 1622-1631; DOI: https://doi.org/10.1124/mol.107.043182
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Polypharmacology of CBL0137 in the African Trypanosome
  • Peptide-mediated differential signaling at GPR83
  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics